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Health care usage in Dutch systemic lupus erythematosus patients
EJM Zirkzee1, GM Steup-Beekman1, AA Schouffoer1, SM Henquet2, MAA Caljouw3,
TWJ Huizinga1 and TPM Vliet Vlieland1,4
1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; 2Department of Radiology, Leiden University Medical
Center, Leiden, Netherlands; 3Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands; and
4Department of Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands
As a first step in the improvement of the organization of care for patients with systemic lupus
erythematosus (SLE) we studied their health care usage and its determinants. A questionnaire
was sent to 161 outpatients of the rheumatology clinic of a Dutch university hospital. The
questionnaire comprised questions on health care usage, quality of life and sociodemographic
characteristics. Disease characteristics were extracted from the medical record. Among the 102
responders (63% response rate) the proportions of patients reporting contacts with a rheu-
matologist because of SLE since onset of the disease and over the past 12 months were 100%
and 83%, respectively. These proportions were 93% and 68% for all other medical specialists,
88% and 44% for the general practitioner, 78% and 44% for any health professional, 29%
and 9% for care at home, 48% and 17% for hospital admissions and 29% and 2% for day-
patient care. Younger age, major organ involvement, the use of immunosuppressants and
worse physical functioning were found to be significantly associated with greater health
care use. This study demonstrated that health care usage by SLE patients is substantial and
involves a variety of health care services. Further research should be directed at patients’
satisfaction and patients’ needs regarding the optimal organization of integrated, multidisci-
plinary services that are accessible for SLE patients of all ages. Lupus (2011) 20, 1147–1154.
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Introduction
Despite a better survival due to advanced medical
treatment, morbidity and mortality associated with
systemic lupus erythematosus (SLE) are still con-
siderable.1,2 Apart from disease activity patients
suffer from the effects of accrued damage, leading
to end-organ dysfunction and functional disability.
Various health care providers are involved in the
management of SLE patients, this may lead to a
lack of cohesive health care and less experienced
care providers.3
As a first step in any effort to improve care, there
should be insight into current health care usage.
Until now, research on the extent of health care
use in SLE patients was scarce. With regard to the
extent of health care use, the proportions of SLE
patients who had contact with a rheumatologist
varied between 78–97% and with a general practi-
tioner between 73–78% over 6–12 months.4,5
Percentages of patients having had contact with
other medical specialists range from 10–33% per
year.4,6 Over periods of six and twelve months, 6
to 22% respectively of SLE patients have had con-
tact with a physical therapist,5,6 whereas the use of
services provided by other health professionals, such
as occupational therapists, dieticians or psycholo-
gists is largely unknown. The proportions of
patients with SLE being admitted to hospital over
a period of a year vary between 18–24% in litera-
ture.6,7 All of these data are from the United States
of America, Canada and the United Kingdom.
A number of studies have examined which fac-
tors were associated with health care usage and/or
health care costs in patients with SLE. Concerning
sociodemographic variables, higher education,5
higher income,4,8 lower age,4,5,9 female sex4 and
ethnic origin other than aboriginal or African–
American9 were found to be associated with
higher health care usage. With respect to disease
characteristics, shorter disease duration,10 higher
levels of creatinine,11 higher levels of disease
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activity,5,10 more end-organ damage5 and worse
functional status5,10,11 have been related to higher
health care usage.
Given that data is only available on a few
selected populations, and there is a lack of infor-
mation on health care usage from onset of disease
and the use of wider health care services, the aim of
this study was to examine the use of all types of




The study had a cross-sectional design. Ethical
approval for this study was obtained from the
Medical Ethical Review Boards of the Leiden
University Medical Center. All participants gave
written informed consent.
Patients
All patients with a diagnosis of SLE as established
by their rheumatologist, who were treated at the
Leiden University Medical Center at the time the
study was conducted, and who had had contact
with their rheumatologist in the previous 24
months were eligible for the study. In addition,
patients had to be fluent in Dutch and had to be
eighteen years or older. Patients were identified by
means of the hospital’s central medical registration
and the diagnosis was confirmed by a rheumatolo-
gist (GMS-B) checking the medical record accord-
ing to the 1982 revised criteria for the classification
of SLE.12,13 A questionnaire was sent to all patients
fulfilling these criteria. The questionnaire was
accompanied by an invitation letter and an infor-
mation leaflet explaining the aim and the methods
of the study and an informed consent form. A
reminder was sent to participants who did not
return the questionnaire within one month. Age,
sex and disease duration were recorded for all
patients, irrespective of their response to the
questionnaire.
Assessment methods
Survey of health care usage
The questionnaire was based on a questionnaire
employed in a previous study among patients with
rheumatoid arthritis.14 It comprised the following
categories of health care services (number of differ-
ent health care professionals/services within a cate-
gory) 1. rheumatologist (n¼ 1); 2. medical
specialists other than rheumatologist (n¼ 10); 3.
general practitioner (n¼ 1); 4. health professionals
(n¼ 6); 5. home care (n¼ 2); 6. hospital admission
(n¼ 1); 7. day patient care (n¼ 1). With every
health care provider or service, patients were
asked ‘Did you have contact with a . . . related to
SLE since the onset of your disease/over the past 12
months?’ (yes/no). If the answer was yes with
respect to the past 12 months, patients were asked
how many contacts or treatment days they had had
(with the exception of home care, where it was
asked how many months patients received home
care). Per category, a category score of 1 was
applied if the answer to one or more care providers
or services was yes, and a score of 0 if all answers
within the category read no. The total health care
usage score was the sum of six of the seven catego-
ries of care (range 0–6). Rheumatologist care was
excluded from the total score as only patients who
had visited the rheumatologist at least once in the
past 24 months were included in this study. Health
care usage was classified as high care usage and
low care usage according to the median total
health care usage score. Finally, patients were
asked if they used complementary medicine (yes/
no) and whether they had had contact with a
patient association (yes/no).
Socio-demographic characteristics
Socio-demographic variables included age; status
of living (living with a partner yes/no); educational
level (primary education (0–8 years; low), second-
ary education (9–16 years; medium) and higher
vocational education/university (postsecondary;
high), paid employment (yes/no) and receiving a
work disability pension (yes/no).
Disease characteristics
Disease duration (years) and history of major
organ involvement (including renal and neuropsy-
chiatric manifestations) were extracted from the
medical record by a rheumatologist (GMS-B). In
addition, the American College of Rheumatology
(ACR) classification criteria at the time of diagno-
sis,12,13 SLE Disease Activity Index (SLEDAI)15
and medication use at the visit closest to filling
out the questionnaire were extracted from the med-
ical record by the principal investigator (EJMZ).
Physical functioning
Physical functioning was measured with a
validated Dutch version of the Health Assessment
Questionnaire (HAQ), a 20-item questionnaire
comprising eight domains of activities of daily
living, with the final score ranging from 0
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(no disability) to 3 (severe disability).16 The HAQ
was found to be a reliable outcome measure for
disability in SLE.17
Quality of life
Quality of life as reflected in physical, mental and
social functioning was measured with the Short
Form (SF)-36, which includes eight domain
scores: physical functioning, role-physical, bodily
pain, general health, vitality, social functioning,
role-emotional, and mental health. The scores of
the SF-36 subscales range from 0–100, with
higher scores indicating better quality of life. The
subscales can be converted into two summary
scales: the physical and mental component sum-
mary scores, standardized to a score with a mean
of 50 and a standard deviation of 10 in the general
population. For that purpose, we used the scores
from an age- and sex-matched, normative sample,
drawn from a large, random, nationwide sample of
adults (n¼ 1742) from the general Dutch popula-
tion Frequency Table and factor score coeffi-
cients.18 The psychometric properties of this
questionnaire have been found to be adequate.19
The SF-36 has been previously used in SLE patients
and proved to have adequate construct, discrimina-
tory and criterion validity in this patient group.20
Data analysis
Descriptive statistics were used for the patients’
characteristics and usage of health care services.
Comparisons between groups of responders versus
non-responders were done by Mann–Whitney and
Chi-square tests where appropriate. To validate the
question on the amount of health care use in the
survey, the number of visits to the rheumatologist
in the past year were retrieved from the hospital’s
central medical registration and compared to the
number of self-reported visits by a paired t-test.
Correlations between variables were investigated
using Pearson correlation coefficients. Logistic
regression models were used with sociodemo-
graphic and disease characteristics as independent
variables and the high or low total health care
usage score as a dependent variable, the results
were expressed as odds ratios (OR) with 95% con-
fidence interval (CI). Univariate logistic regression
analyses were performed. All variables that showed
univariate significance (p< 0.05) associated with
total health care usage score were entered into mul-
tivariate analysis. The multivariate analysis was
repeated by entering all variables that were univari-
ately associated (p< 0.10) with the health care
usage score. All analyses were adjusted for sex,
age and disease duration. p-values< 0.05 were con-
sidered to be statistically significant. Data entry
was performed using Netquestionnaires 2005.




The questionnaire was returned by 102 of the 161
eligible patients (63%). The sociodemographic and
disease characteristics of these patients are shown
in Table 1. Their median age was 45 years (range
18–76) and their median disease duration 9 years
(range 1–29). The 59 patients who did not respond
had a median age of 39 years (range 19–81), which
is significantly younger than the patients who did
respond (p¼ 0.03). In addition, in the group of
non-responders the average disease duration was
longer (median 13 years, range 1–29) and fewer
patients were female (n¼ 49, 83%), although
these results did not reach statistical significance
(p¼ 0.06 and p¼ 0.13, respectively).
Validation of health care usage
The mean number of visits to the rheumatologist
over the past year as derived from the hospital’s
central medical registration was 2.8 (SD 1.8),
which did not differ significantly from the number
reported by patients themselves (mean 3.2;
SD 2.4) (p¼ 0.61).
Description of use of care
The use of health care services by patients is shown
in Table 2. Patients had contact with a median of
five (range 1–10) physicians since the onset of dis-
ease, with the rheumatologist, general practitioner,
dermatologist, internist, neurologist and cardiolo-
gist most frequently mentioned, in this order. Ten
patients had had contact with six medical specialists
other than their rheumatologist since onset of dis-
ease. Seventy-eight per cent of patients had contact
with one or more health professionals (median 2,
range 0–6) since onset of disease, with the physio-
therapist being most frequently mentioned.
Complementary therapy was used by 22% of
patients and 44% joined a patient association.
In last 12 months patients had contact with a
median of 2 (range 0–6) medical specialists (includ-
ing rheumatologists) with a mean of 11 outpatient
visits. In the last twelve months 44% of patients
had contact with one or more health professionals
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(median 0, range 0–5). In the total population
patients had a mean of 13 visits per year to health
professionals, if only counted for patients who had
at least 1contact there were 31 visits per patient per
year. Seventeen patients (16.7%) had been admit-
ted to the hospital with a mean stay of seven days.
Nine patients (8.8%) had had home help for a
mean of ten months in the last twelve months. In
total patients had a median use of 2 (range 0–5)
different services in last 12 months.
Determinants of health care utilization
Table 3 shows univariate and multivariate (entry
criterion of variables p< 0.05 in univariate analy-
sis) regression analysis of sociodemographic and
disease characteristics of high and low care users
as classified by median of total health care usage
scores in the last twelve months. In the multivariate
analysis lower age, major organ involvement, the
use of immunosuppressants and worse HAQ were
found to be significantly associated with health care
usage. Repetition of the multivariate analysis enter-
ing all variables that were associated with health
care usage in the univariate analysis using a level
of significance of 0.10 yielded similar results, with
the following significant associations: Age, odds
ratio (OR) 0.94 (95% confidence interval (CI)
0.89–0.99, p< 0.05); Immunosuppressants (includ-
ing corticosteroids), OR 3.28 (95% CI 1.03–10.44,
p< 0.05); SF-36 Role-emotional, OR 0.98 (95% CI
0.97–1.00, p< 0.05); HAQ, OR 6.51 (95% CI 1.09–
38.88, p< 0.05).
Outcomes of SF-36 physical functioning subscale
and HAQ, both addressing physical activities, were
found to be strongly correlated (r¼0.8, p< 0.01)
Therefore we performed the multivariate analysis
(entry criterion p< 0.05) with only one of the two
variables at a time. When only the HAQ was
entered, the OR for the HAQ score was 5.63
(95% CI 1.85–17.16, p< 0.01), whereas entering
only the SF-36 physical functioning subscale
resulted in an OR of 0.97 (95% CI 0.94–0.99,
p< 0.01) for that variable.
Discussion
In this cross-sectional study among Dutch SLE
patients, health care use was found to be substan-
tial and included all categories of health care.
Younger age, major organ involvement, the use of
immunosuppressants and worse physical function-
ing were found to be significantly associated with
greater use of health care.
With respect to the extent of health care use, the
proportions of patients reporting contact with med-
ical specialists other than a rheumatologist in our
study were higher than in the literature, but the
Table 1 Sociodemographic and disease characteristics of 102
SLE patients
Characteristic
Age, years; mean (SD) 45 (13.7)
Duration of disease, years; mean (SD) 11 (7.4)
Female; N (%) 94 (92)
Caucasian origin; N (%) 90 (88)




Paid employment; N (%) 56 (55)
Work disability pension; N (%) 32 (31)
Living alone; N (%) 19 (19)
No. of ACR criteria at time of diagnosis
(0–11), mean (SD)
4.5 (0.8)
Cumulative ACR manifestations at time
of diagnosis,%
Malar rash 29 (28)
Discoid rash 17 (17)
Photosensitivity 30 (30)
Oral ulcerations 23 (23)
Arthritis 76 (75)
Serositis 33 (32)
Renal disorder 24 (24)
Neurologic disorder 2 (2)
Hematologic disorder 50 (49)
Immunologic disorder 75 (74)
Antinuclear antibody 96 (94)
SLEDAI score (0–105), mean (SD) 2.2 (2.9)
Major organ involvement; N (%)
None 50 (49)
Renal involvement 15 (15)
Neuropsychiatric involvement 17 (17)
Renal and neuropsychiatric involvement 20 (19)






SF-36 Scales (0–100); Mean (SD)
Physical functioning 68.4 (25.1)
Role-physical 47.5 (41.8)
Bodily pain 68.7 (20.8)
General health 35.5 (19.4)
Vitality 51.2 (17.2)
Social functioning 66.3 (23.8)
Role-emotional 69.0 (42.8)
Mental health 55.8 (12.4)
Physical Component Summary 56.3 (21.8)
Mental Component Summary 60.8 (19.4)
Health Assessment Questionnaire score (0–3);
Mean (SD)
0.48 (0.60)
ACR: American College of Rheumatology, SD: standard deviation,
SLE: systemic lupus erythematosus, SLEDAI: Systemic Lupus
Erythematosus Disease Activity Index.
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pattern of involvement of medical specialists was
the same.4,6 The proportions of patients that
reported contact with a rheumatologist also was
the same.4 Concerning contacts with a general prac-
titioner, the rates in our study were lower than
reported in the literature.4 For the use of health
professionals’ care comparisons are difficult to
make, due to lack of available data. The proportion
of patients that reported contact with a physical
therapist was much higher than reported in the lit-
erature.6 Our study demonstrated, that in addition,
a considerable proportion of patients had contacts
with other health professionals such as psycholo-
gists, dieticians or occupational therapists. The
rate of patients being admitted in hospital was
slightly lower than reported elsewhere.6,7 The pro-
portion of patients in our population reporting use
of complementary care was much lower than in the
literature.21
With respect to the frequency of contacts with
care providers per year, patients in our population
had a number of outpatient visits to medical spe-
cialists and general practitioners comparable to lit-
erature, for instance in Canada patients had a mean
of 15 and 2 visits per year, respectively.22 Also
patients in our population reported contacts with
a rheumatologist as often as found in the
literature.23 Concerning health professionals the
patients in our population reported many more
contacts than found in the literature, for instance
in Canada patients had a mean of two visits per
year.22 No data on care at home or day patient
care was available for comparison. Comparison of
our data with that of other studies is compromised
by differences in population, local differences in
health insurance and logistics of care. However,
patients from Canada included in the Tri-Nation
Study Group seem applicable for comparison,
because sociodemographic characteristics, scores
on SF-36 subscales and collection of data on
health care service utilization are quite comparable
to our population, therefore data is shown above.
In line with available literature, the HAQ score
in our study was found to be significantly associ-
ated with health care usage. Functional status is a
widely recognized determinant of health care use in
SLE patients.5,10,11 Also in line with the available
literature, in our population, younger age was sig-
nificantly associated with greater use of health care
services, especially medical specialist care.4,5,9 This
finding could theoretically be related to a more
active disease and/or shorter disease duration in
younger patients.24,25 However, the multivariate
analyses were adjusted for disease duration and
Table 2 Health care usage of 102 patients with SLE
Health care service
Contact since onset
of disease N (%)
Contact in last
12 months N (%)
Number of visits per patient in last 12 months,
if at least one Mean (SD)
Rheumatologist 102 (100) 85 (83) 3.2 (2.4)
Medical specialistsa 95 (93) 69 (68) 7.7 (5.6)
Internist 58 (60) 15 (15) 2.3 (1.2)
Nephrologist 35 (34) 23 (23) 4.6 (3.0)
Pulmonologist 36 (35) 10 (10) 2.5 (1.6)
Cardiologist 45 (44) 16 (16) 1.8 (1.1)
Dermatologist 62 (61) 25 (25) 2.9 (1.7)
Neurologist 47 (46) 14 (14) 2.4 (1.0)
Psychiatrist 18 (18) 2 (2) 8.5 (5.0)
ENT-specialist 25 (25) 7 (7) 1.5 (0.6)
Gynaecologist 15 (15) 10 (10) No data
General practitioner 90 (88) 45 (44) 2.8 (1.7)
Health professionals 79 (78) 45 (44) 31.0 (32.8)
Physiotherapist 62 (61) 26 (26) 43.7 (31.6)
Occupational therapist 22 (22) 8 (8) 2.4 (1.5)
Nurse specialist 27 (27) 8 (8) 2.9 (2.9)
Dietician 32 (31) 14 (14) 3.3 (3.6)
Social worker 30 (29) 7 (7) 4.7 (3.4)
Psychologist 22 (22) 10 (10) 6.1 (2.4)
Care at home 30 (29) 9 (9)
Home help 20 (20) 9 (9)
Community nurse 18 (18) 2 (2)
Hospital admission 44 (43) 17 (17)
Day patient care 30 (29) 2 (2)
aOther than a rheumatologist, ENT: ear nose and throat, SD: standard deviation, SLE: systemic lupus erythematosus.
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clinical variables including disease activity and
major organ involvement but age was still signifi-
cantly associated with health care usage. Major
organ involvement is a known and foreseeable
determinant for health care usage.5 The use of
immunosuppressants as a determinant for health
care usage was not formerly reported. In the
repeated multivariate analysis (entry criterion of
variables: p< 0.10) SF-36 Role-emotional was
also significantly associated with health care
usage, emphasizing the importance of emotional
functioning as a determinant for health care usage
in SLE patients.
This study has limitations. First, our cohort is a
selection of patients who are under the care of a
rheumatologist in a university hospital. The patient
population may however be comparable to SLE
patients under the care of rheumatologists in
general hospitals, as our hospital is the only hospi-
tal offering rheumatology services in the Leiden
region. Age, gender and disease duration of
patients in our study are comparable to the three
populations in a study that describes patients
attending various clinics in a period of 24
months.22 Moreover, the distribution of ACR cri-
teria at diagnosis in our patient population is sim-
ilar to the ACR 82 cohort.12 The number of ACR
criteria is relatively low because they were counted
at the time of diagnosis. Although the proportion
of responders was relatively high, it appears that
older, female patients with shorter disease duration
were over-represented. Secondly, the amount of
health care usage is a patient-reported outcome
potentially leading to recall-bias. However, in our
study the numbers of patient-reported and officially
recorded visits to the rheumatologist in the past
year were not significantly different. This finding
is in line with the literature, where patients’ reports
were found to be as valid as providers’ reports for
hospital days and outpatient visits.26










Age, years; mean (SD) 41.9 (13.9) 46.1 (13.4) 0.98 (0.95–1.01) 0.95 (0.90–0.99)*
Duration of disease, years; mean (SD) 9.7 (7.7) 11.0 (7.2) 0.98 (0.92–1.03) 0.92 (0.84–1.01)g
Female; N (%) 35 (37%) 59 (63%) 0.59 (0.14–2.52) 0.54 (0.06–4.65)
Caucasian origin; N (%) 33 (37%) 57 (63%) 0.46 (0.13–1.63)
Educational level; N (%)
Low 7 (44%) 9 (56%) 1.26 (0.38–4.12)
Medium 15 (33%) 31 (67%) Reference cat.
High 16 (42%) 22 (58%) 1.37 (0.57–3.28)
Paid employment; N (%) 19 (34%) 37 (66%) 0.67 (0.30–1.49)
Work disability pension; N (%) 14 (44%) 18 (56%) 1.40 (0.60–3.28)
Living alone; N (%) 8 (42%) 11 (58%) 1.22 (0.44–3.36)
No. of ACR criteria at time of diagnosis; mean (SD) 4.6 (0.7) 4.5 (0.9) 1.24 (0.77–2.02)
SLEDAI score; mean (SD) 3.0 (3.5) 1.8 (2.4) 1.15 (0.99–1.33)g
Major organ involvement; N (%) 25 (48%) 27 (52%) 2.38 (1.05–5.42)* 3.51 (1.06–11.56)*
Medication; N (%)
Any medication 38 (40%) 58 (60%) 3.28 (0.37–29.14) 3.02 (1.02–8.93)*
Immunosuppressants (including corticosteroids) 28 (56%) 22 (44%) 4.74 (1.99–11.31)1
SF-36 Scales (0–100); mean (SD)
Physical functioning 58.3 (27.4) 74.8 (21.5) 0.97 (0.96–0.99)1 1.00 (0.96–1.04)
Role-physical 37.8 (40.5) 53.6 (41.7) 0.99 (0.98–1.00)g
Bodily pain 65.0 (21.8) 71.0 (20.0) 0.99 (0.97–1.01)
General health 34.3 (18.1) 44.6 (22.1) 0.98 (0.96–0.97)* 0.98 (0.95–1.01)
Vitality 49.0 (12.5) 52.6 (19.0) 0.99 (0.97–1.01)
Social functioning 62.2 (21.9) 68.8 (24.8) 0.99 (0.97–1.01)
Role-emotional 58.1 (46.3) 75.7 (39.4) 0.99 (0.98–1.00)* 0.99 (0.98–1.00)g
Mental health 54.0 (12.5) 63.5 (18.9) 0.98 (0.95–1.01)
Physical component summary 48.9 (21.3) 60.9 (20.9) 0.98 (0.96–1.00)g
Mental component summary 56.3 (19.5) 63.5 (18.9) 0.98 (0.96–1.00)g
Health Assessment Questionnaire score (0–3); mean (SD) 0.72 (0.70) 0.32 (0.46) 3.23 (1.55–6.73)1 5.22 (1.00–27.08)*
1p< 0.01, *p< 0.05, gp< 0.10.
ACR: American College of Rheumatology, SD: standard deviation, SLE: systemic lupus erythematosus, SLEDAI: Systemic Lupus Erythematosus
Disease Activity Index.
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Another limitation is that emergency room visits
were not taken into account separately. In case of
emergencies related to their disease, patients usu-
ally come to the outpatient clinic and not to the
emergency room. If emergency room visits had
been counted, the rates would most probably be
falsely low.
This study demonstrated that SLE patients make
considerable use of health care, including all cate-
gories of health care services; this use was grossly
comparable to other available data. Especially inter-
esting are the substantial contacts with health pro-
fessionals, not reported formerly. Lower age was the
only sociodemographic variable that determined
health care usage. This needs further investigation
to show if there is underuse of health care in the
elderly, overuse in young patients or if this differ-
ence is explained by factors related to the disease
that were not accounted for in this study.
The great number of health care services
involved in the care of an SLE patient has led to
confusing situations3 and possibly overlap in
actions. Frequent visits to health care facilities to
meet with several care providers individually, may
raise practical concerns and a higher disease burden
for the patient. On the other hand in recent studies
there are unmet needs in SLE patients.27,28
Therefore, it seems plausible that the extensive
and complicated use of health care in SLE patients
can be improved in the nearby future.
Improvements should involve patient’s wishes
and medical needs combined in modalities of
health care services that are most financially effi-
cient.29,30 This could best be done in specialized
hospitals with physicians who can build experience
with this complicated disease.31,32 Probably experi-
ence with SLE patients also improves quality in
allied health care, which proved to play an impor-
tant role in this population. Clarke demonstrated
earlier that higher costs do not necessarily lead to
better health outcomes.33 Although the opposite,
worse outcome in a managed care system trying
to reduce costs, was experienced in Puerto Rico.34
A future challenge lies in investigating unmet needs,
satisfaction with care and health outcomes related
to care in SLE patients and developing a cost effi-
cient, multidisciplinary approach to coordinate
care for SLE patients of all ages.
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